TrialJAMA network open2023

Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Eric X Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.